Your browser doesn't support javascript.
loading
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Planchais, Cyril; Fernández, Ignacio; Bruel, Timothée; de Melo, Guilherme Dias; Prot, Matthieu; Beretta, Maxime; Guardado-Calvo, Pablo; Dufloo, Jérémy; Molinos-Albert, Luis M; Backovic, Marija; Chiaravalli, Jeanne; Giraud, Emilie; Vesin, Benjamin; Conquet, Laurine; Grzelak, Ludivine; Planas, Delphine; Staropoli, Isabelle; Guivel-Benhassine, Florence; Hieu, Thierry; Boullé, Mikaël; Cervantes-Gonzalez, Minerva; Ungeheuer, Marie-Noëlle; Charneau, Pierre; van der Werf, Sylvie; Agou, Fabrice; Dimitrov, Jordan D; Simon-Lorière, Etienne; Bourhy, Hervé; Montagutelli, Xavier; Rey, Félix A; Schwartz, Olivier; Mouquet, Hugo.
Afiliação
  • Planchais C; Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, Paris, France.
  • Fernández I; INSERM U1222, Paris, France.
  • Bruel T; Institut Pasteur, Université Paris Cité, Structural Virology Unit, Paris, France.
  • de Melo GD; CNRS UMR3569, Paris, France.
  • Prot M; CNRS UMR3569, Paris, France.
  • Beretta M; Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, Paris, France.
  • Guardado-Calvo P; Institut Pasteur, Université Paris Cité, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France.
  • Dufloo J; Institut Pasteur, Université Paris Cité, G5 Evolutionary Genomics of RNA Viruses, Paris, France.
  • Molinos-Albert LM; Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, Paris, France.
  • Backovic M; INSERM U1222, Paris, France.
  • Chiaravalli J; Institut Pasteur, Université Paris Cité, Structural Virology Unit, Paris, France.
  • Giraud E; CNRS UMR3569, Paris, France.
  • Vesin B; CNRS UMR3569, Paris, France.
  • Conquet L; Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, Paris, France.
  • Grzelak L; Institut Pasteur, Université Paris Cité, Laboratory of Humoral Immunology, Paris, France.
  • Planas D; INSERM U1222, Paris, France.
  • Staropoli I; Institut Pasteur, Université Paris Cité, Structural Virology Unit, Paris, France.
  • Guivel-Benhassine F; CNRS UMR3569, Paris, France.
  • Hieu T; Institut Pasteur, Université Paris Cité, Chemogenomic and Biological Screening Core Facility, C2RT, Paris, France.
  • Boullé M; Institut Pasteur, Université Paris Cité, Chemogenomic and Biological Screening Core Facility, C2RT, Paris, France.
  • Cervantes-Gonzalez M; Pasteur-TheraVectys, Paris, France.
  • Ungeheuer MN; Institut Pasteur, Université Paris Cité, Molecular Virology & Vaccinology Unit, Paris, France.
  • Charneau P; Institut Pasteur, Université Paris Cité, Mouse Genetics Laboratory, Paris, France.
  • van der Werf S; CNRS UMR3569, Paris, France.
  • Agou F; Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, Paris, France.
  • Dimitrov JD; CNRS UMR3569, Paris, France.
  • Simon-Lorière E; Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, Paris, France.
  • Bourhy H; CNRS UMR3569, Paris, France.
  • Montagutelli X; Institut Pasteur, Université Paris Cité, Virus & Immunity Unit, Paris, France.
  • Rey FA; Institut Pasteur, Université Paris Cité, Functional Genetics of Infectious Diseases Unit, Paris, France.
  • Schwartz O; Institut Pasteur, Université Paris Cité, Chemogenomic and Biological Screening Core Facility, C2RT, Paris, France.
  • Mouquet H; Department of Epidemiology, Biostatistics and Clinical Research, Assistance Publique-Hôpitaux de Paris, Bichat Claude Bernard University Hospital, INSERM CIC-EC 1425, Paris, France.
J Exp Med ; 219(7)2022 07 04.
Article em En | MEDLINE | ID: mdl-35704748
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França